The press center of Izvestia International Medical Center will tell about the first Russian drugs from donated blood plasma

On June 15, at 14:00, a press conference on the development and implementation of Russian drugs based on donated blood plasma will be held at the Izvestia press center.

How was the hemophilia drug developed and how does it differ from other analogues? How is donor plasma used in the manufacture of medicines? In what cases are plasma medications used, including emergency and elective surgeries? Why are these drugs considered strategically important for the treatment of severe infections, blood loss, and emergency medicine?

Participants:

-Tatiana Gaponova, Chief Freelance Transfusiologist at the Ministry of Health of the Russian Federation, First Deputy General Director of the Federal State Budgetary Institution "NMITS of Hematology" of the Ministry of Health of the Russian Federation, MD.;

- Evgeny Golubev, Head of the Experimental Production Department of Deep Plasma Processing at the National Research Medical Center of Hematology of the Ministry of Health of the Russian Federation.

For accreditation to the press center, you must send an email press-center@iz.ru send the full name, series and passport numbers of the film crew.

Important: The event can also be attended ONLINE. Media representatives can participate in the press conference remotely with prior accreditation.

To do this, send your full name, the name of the media outlet, and the mobile number linked to the installed Telegram application.

Media accreditation: press-center@iz.ru , tel. (495) 937-61-70, ext. 4805, 4236

Entrance for media representatives is subject to prior accreditation upon presentation of a passport or press card.

Address: Moscow, Party lane, 1, room 57, building 3, 2nd floor.

Learn more about the events of the press center on the website.